| Erasca Lands $200M Mega-Round to Move Cancer Programs to the Clinic | Sarah de Crescenzo | 04/27/20 | San Diego |
| ORIC Pharma Plans IPO to Test Therapies for Drug-Resistant Cancers | Sarah de Crescenzo | 03/02/20 | San Francisco |
| Eying “Extra” DNA As Cancer Driver, Boundless Bio Debuts With $46M | Sarah de Crescenzo | 09/19/19 | San Diego |
| Four New Drugs Are Around the Corner. Here’s What You Need to Know. | Ben Fidler | 08/15/19 | National |
| ASCO Abstracts: Breast Cancer, Precision Treatments in the Spotlight | Ben Fidler | 05/16/19 | National |
| With $42M, Ex-Ignyta CEO Aims At Cancer Again With Startup, Erasca | Sarah de Crescenzo | 12/18/18 | San Diego |
| Another Precision Step for Roche as Ignyta Drug Heads to Regulators | Ben Fidler | 09/24/18 | San Francisco |
| Bio Roundup: Drug Prices, CRISPR Caveats, Rubius IPO Pop & More | Ben Fidler | 07/20/18 | National |
| Roche Bets $1.7B More on Precision Oncology With Ignyta Deal | Ben Fidler | 12/22/17 | San Diego |
| In a Precision Step, Bayer Writes Loxo $400M Check for Two Cancer Drugs | Ben Fidler | 11/14/17 | New York |
| Precision Steps: Can Loxo Drug Help Broaden Use of Cancer DNA Tests? | Ben Fidler | 06/03/17 | National |
| In Turnaround Saga, Ignyta Nears Crucial Phase in Cancer Drug Trial | Bruce V. Bigelow | 09/23/16 | San Diego |
| Advancing Drugs at Roche, Sophiris, Coherus, and Other Bio News | Bruce V. Bigelow | 11/13/15 | San Diego |
| West Coast Biotech Roundup: Avalanche, CytomX, BioMarin, Dubs & More | Alex Lash | 06/19/15 | San Francisco |
| West Coast Biotech Roundup: Juno, Nektar, Kite, Glooko & More | Alex Lash | 03/19/15 | Seattle |
| West Coast Biotech Roundup: Laguna, SeaGen, Unchained, DME & More | Alex Lash | 02/19/15 | San Francisco |
| San Diego Life Sciences Roundup: Zogenix, Ignyta, AnaptysBio, & More | Bruce V. Bigelow | 03/17/14 | San Diego |
| Ignyta Receives $47,580,000 New Round | VentureDeal | 03/14/14 | San Diego |
| San Diego Life Sciences Roundup: Acadia, Ignyta, Tracon, & More | Bruce V. Bigelow | 03/07/14 | San Diego |
| San Diego Life Sciences Roundup: Receptos, Auspex, Avelas, and More | Bruce V. Bigelow | 01/10/14 | San Diego |
| Ignyta Secures $10,000,000 New Funding Round | VentureDeal | 01/06/14 | San Diego |
| San Diego Life Sciences Roundup: Orexigen, Accelrys, Otonomy, & More | Bruce V. Bigelow | 12/13/13 | San Diego |
| Q&A: Behind Ignyta’s New Strategy on Cancer Drugs and Diagnostics | Bruce V. Bigelow | 12/09/13 | San Diego |
| San Diego Life Sciences Roundup: Ignyta, Conatus, Liver Prize & More | Bruce V. Bigelow | 12/06/13 | San Diego |
| San Diego Life Sciences Roundup: Santarus, Cytori, IPOs, and More | Bruce V. Bigelow | 11/08/13 | San Diego |
| San Diego Life Sciences Roundup: Effector, Ignyta, and More | Bruce V. Bigelow | 05/23/13 | San Diego |
| San Diego Life Sciences Roundup: Optimer, Zogenix, MediciNova, & More | Bruce V. Bigelow | 03/01/13 | San Diego |
| Ignyta Lands $6,000,000 Series B Financing | VentureDeal | 01/01/13 | San Diego |
| City Hill Leads $6M Financing to Pioneer RA Diagnostics at Ignyta | Bruce V. Bigelow | 12/31/12 | San Diego |
